Reenal Gandhi is Global Business Development Director within Aptar Pharma’s Prescription division, where she is responsible for driving the assessment of potential new opportunities, with a specific focus on new technologies.
Until December 2020, she was Business Development Director at Bespak by Recipharm, where she was responsible for business development activities related to nasal devices and injectable devices such as autoinjectors and wearable injection systems.
Ms Gandhi has more than 15 years of experience in both the drug delivery device and pharma industries, developing and commercialising drug delivery solutions for biotech, vaccines and pharma. Throughout her career, she has been active in business development activities related to nasal devices and injectable devices such as prefilled syringes and autoinjectors. Her interest lies in developing combination products with drug delivery devices, balancing formulation, technology and commercial potential.